Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Mindray Medical International Limited ADR r ( MR) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.5%. By the end of trading, Mindray Medical International Limited ADR r rose $2.53 (6.8%) to $39.52 on heavy volume. Throughout the day, 2,664,735 shares of Mindray Medical International Limited ADR r exchanged hands as compared to its average daily volume of 1,062,600 shares. The stock ranged in a price between $36.84-$40.89 after having opened the day at $37.00 as compared to the previous trading day's close of $36.99. Other companies within the Health Services industry that increased today were: IsoRay ( ISR), up 75.6%, Rosetta Genomics ( ROSG), up 18.2%, American Caresource Holdings ( ANCI), up 15.8% and Retractable Technologies ( RVP), up 11.7%.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International Limited ADR r has a market cap of $4.4 billion and is part of the health care sector. The company has a P/E ratio of 20.3, above the S&P 500 P/E ratio of 17.7. Shares are up 1.7% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Mindray Medical International Limited ADR r a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Mindray Medical International Limited ADR r as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front, BG Medicine ( BGMD), down 11.2%, CAS Medical Systems ( CASM), down 8.8%, Sunshine Heart ( SSH), down 8.8% and Volcano Corporation ( VOLC), down 7.5% , were all laggards within the health services industry with UnitedHealth Group ( UNH) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.